BCM
CHAQ.WS

BlueCrest Capital Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

BlueCrest Capital Management’s Portfolio CHAQ.WS Stock Details CHAQ.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-250,000
Closed -$160K – 605
2021
Q2 		$160K Hold
250,000
– – ﹤0.01% 487
2021
Q1 		$235K Buy
250,000
+221,239
+769% +$245K ﹤0.01% 616
2020
Q4 		$29K Buy
+28,761
New +$21.8K ﹤0.01% 358

BlueCrest Capital Management's CHAQ.WS Position: Q3 2021 in Review

BlueCrest Capital Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 250,000 shares — an estimated $160K sold.

BlueCrest Capital Management first reported a position in CHAQ.WS in Q4 2020 and held it in 3 quarters. The position peaked at $235K in Q1 2021. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

  • BlueCrest Capital Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
  • BlueCrest Capital Management sold 250,000 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $160K.
  • BlueCrest Capital Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q4 2020 and held it in 3 quarters.
  • BlueCrest Capital Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $235K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on BlueCrest Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.